Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 242.00 | 278.25 | 0.8697 | 0.6991 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 275.00 | 278.25 | 0.9883 | 0.9727 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 166.00 | 278.25 | 0.5966 | 0.0939 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 324.00 | 278.25 | 1.1644 | 1.3892 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 316.00 | 278.25 | 1.1357 | 1.3205 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 284.00 | 278.25 | 1.0207 | 1.0484 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 348.00 | 278.25 | 1.2507 | 1.5973 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 312.50 | 153.73 | 327.00 | 278.25 | 1.1752 | 1.4151 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 350.00 | 278.25 | 1.2579 | 1.6147 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 312.50 | 153.73 | 351.00 | 278.25 | 1.2615 | 1.6234 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 416.00 | 278.25 | 1.4951 | 2.1994 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 335.00 | 278.25 | 1.2040 | 1.4843 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 312.50 | 153.73 | 129.00 | 278.25 | 0.4636 | -0.1852 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 321.00 | 278.25 | 1.1536 | 1.3634 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 334.00 | 278.25 | 1.2004 | 1.4756 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 312.50 | 153.73 | 131.00 | 278.25 | 0.4708 | -0.1705 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 312.50 | 153.73 | 291.00 | 278.25 | 1.0458 | 1.1075 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 262.00 | 278.25 | 0.9416 | 0.8642 | |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 342.00 | 278.25 | 1.2291 | 1.5450 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 295.00 | 278.25 | 1.0602 | 1.1413 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 153.73 | 341.00 | 278.25 | 1.2255 | 1.5363 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 146.00 | 278.25 | 0.5247 | -0.0585 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 236.00 | 278.25 | 0.8482 | 0.6500 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 669.00 | 795.50 | 0.8410 | 0.7529 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 625.00 | 320.09 | 753.00 | 795.50 | 0.9466 | 0.9181 |